PrEP

Gilead will challenge US government patent on PrEP drug Truvada

https://pharmaphorum.com/news/gilead-will-challenge-us-government-patent-on-prep-drug-truvada/

Gilead’s Descovy gets FDA panel OK for PrEP, but not for women

https://pharmaphorum.com/news/gileads-descovy-gets-fda-panel-ok-for-prep-but-not-for-women/

FDA reviewer backs Gilead’s Descovy for PrEP, but not in women

https://pharmaphorum.com/news/fda-reviewer-backs-gileads-descovy-for-prep-but-not-in-women/

MPs call for NHS funding for HIV prevention drug

https://pharmaphorum.com/news/mps-call-for-nhs-funding-for-hiv-truvada/

Landmark HIV prophylaxis trial to begin next month

https://pharmaphorum.com/news/hiv-prophylaxis-trial/

Scotland says yes to Truvada as PrEP

https://pharmaphorum.com/news/scotland-says-yes-truvada-prep/

NHS England confirms HIV prevention funding – but only via clinical trial

https://pharmaphorum.com/news/nhs-england-extend-hiv-prevention-programme/

UK court victory for access to HIV prevention drug

https://pharmaphorum.com/news/nhs-make-decision-gilead-hiv-prevention-drug/

Gilead donates Truvada to HIV trial patients

https://pharmaphorum.com/news/gilead-donates-truvada-prep-trial-patients/

1 2

Close in 10 seconds

Pharmaphorum.com

Search